2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (ADMIN-CORE)

摘要 行政核心的任务是促进联合国的能力建设和培训任务 加州大学河滨分校(UCR)-希望之城综合癌症中心(CoH-CCC)P20 程序。UCR和CoH-CCC都致力于向P20绩效指标和调查人员提供必要的 资源，包括受保护的时间和文书援助。行政核心将提供科学的 领导、行政和财政管理。核心将由P20派的欧内斯特·马丁内斯博士领导。 (UCR)和Victoria Seewaldt，M.D.(CoH)。P20 PI都是由R01资助的，并致力于培训 代表不足的少数族裔。 外部咨询委员会(EAB)和内部咨询委员会(IAB)将帮助指导我们的P20规划， 实施和评估。我们将共同制定初步计划，确定优先事项，并实施和 评估我们是否达到了P20的目标和里程碑。 我们的EAB领导人完全有资格指导我们的P20伙伴关系。EAB成员是世界领先的 健康科学的差异，并领导自己的P20和U54赠款。EAB成员包括：Elana 马丁内斯博士(加州大学圣地亚哥分校)、卢西奥·米勒医学博士(路易斯安那州立大学)、里卡多·理查森博士(NCCU)和罗伯特 维恩，医学博士(伊利诺伊大学，芝加哥)。EAB领导人将每年在现场举行会议，评估 P20。 我们的IAB成员是UCR和CoH-CCC的高级领导人。UCR IAB成员包括：Dr Kelechi Kalu博士，副教务长兼政治学教授，France Sladek博士，细胞学教授 生物学和毒理学。COH-CCC IAB领导人包括David Horne，博士，CoH-CCC Development 治疗项目和Beckman治疗主任和Linda Malkas博士，翻译学院院长 科学与对外事务协会与加州干细胞转化研究理事会 程序。IAB和P20领导人将每季度举行一次会议，如果需要，还将举行更频繁的会议，以提供战略指导， 我们的P20伙伴关系项目的政策制定和评估。

ABSTRACT The mission of the Administrative Core is to facilitate the capacity building and training mission of the University of California Riverside (UCR) - City of Hope Comprehensive Cancer Center (CoH-CCC) P20 Program. Both UCR and CoH-CCC are committed to providing the P20 PIs and investigators with necessary resources including protected time and clerical assistance. The Administrative Core will provide scientific leadership, administration, and fiscal management. The Core will be led by P20 PI's, Ernest Martinez, Ph.D. (UCR) and Victoria Seewaldt, M.D. (CoH). The P20 PI's are both R01 funded and are committed to training of underrepresented minorities. External Advisory Board (EAB) and Internal Advisory Board (IAB) will help guide our P20 planning, implementation, and evaluation. Together, we will develop initial plans, set priorities, and implement and evaluate whether we meet our P20 goals and milestones. Our EAB leaders are well-qualified to guide our P20 Partnership. EAB members are world leaders in the health science of disparities and lead their own P20 and U54 grants. EAB members include: Elana Martinez, Ph.D. (UC San Diego), Lucio Miele, M.D. (LSU), Ricardo Richardson, Ph.D. (NCCU), and Robert Winn, M.D. (University of Illinois, Chicago). EAB leaders will meet on site yearly to evaluate progress of the P20. Our IAB members are senior leaders within UCR and CoH-CCC. UCR IAB members include: Dr. Kelechi Kalu, Ph.D., Vice Provost and Professor of Political Science and Dr. Frances Sladek, Professor of Cell Biology and Toxicology. CoH-CCC IAB leaders include David Horne, Ph.D., CoH-CCC Developmental Therapeutics Program and Beckman Therapeutic Director and Linda Malkas, Ph.D., Dean of Translational Science and External Affairs CoH-CCC and Board of Directors California Stem Cell Translational Research Program. IAB and P20 leaders will meet quarterly, or more frequently if needed, to provide strategic direction, policy development, and evaluation of our P20 Partnership Project.